Graziana Carleo

Dr. Graziana Carleo


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Damiano PaolicelliDamiano Paolicelli
Damiano Paolicelli
Maddalena RuggieriMaddalena Ruggieri
Maddalena Ruggieri
AMAlessia Manni
Alessia Manni
CGConcetta Domenica Gargano
Concetta Domenica Gargano
GCGraziana Carleo
Graziana Carleo
MTMaria Trojano
Maria Trojano
Although cladribine induces sustained reductions in peripheral T and B lymphocytes, little is known about its effect on axonal damage reduction in multiple sclerosis (MS), which could be demonstrated by assessing the serum neurofilament light chain (sNfL) levels. We investigated the reduction/reconstitution of different lymphocyte subsets (LS) by verifying the correlation with no evidence of disease activity (NEDA) and the variation in sNfL levels during cladribine treatment. We analysed 33 highly active relapsing MS patients and followed them up for 12 ± 3.3 months; blood samples were collected at treatment start (W0) and after 8, 24 and 48 weeks. Seventeen patients (60.7%) showed NEDA during the first treatment. At week 8, we observed a significant decrease in B memory cells, B regulatory 1 CD19+/CD38+ and B regulatory 2 CD19+/CD25+, a significant increase in T regulatory CD4+/CD25+, a slight increase in T cytotoxic CD3+/CD8+ and a non-significant decrease in T helper CD3+/CD4+. Starting from week 24, the B subsets recovered; however, at week 48, CD19+/CD38+ and CD19+/CD25+ reached values near the baseline, while the Bmem were significantly lower. The T cell subsets remained unchanged except for CD4+/CD25+, which increased compared to W0. The LS changes were not predictive of NEDA achievement. The sNfL levels were significantly lower at week 24 (p = 0.046) vs. baseline. These results could demonstrate how cladribine, by inflammatory activity depletion, can also reduce axonal damage, according to the sNfL levels.

18 January 2024 in Cancers
Verified
Journal Article
Open access
PDF file
ESElisa Sicolo
Elisa Sicolo
CZCarmelina Cristina Zirafa
Carmelina Cristina Zirafa
GRGaetano Romano
Gaetano Romano
JBJury Brandolini
Jury Brandolini
Angela De PalmaAngela De Palma
Angela De Palma
FMFranca M.A. Melfi
Franca M.A. Melfi
Thymectomy is the gold standard in the treatment of thymic neoplasm and plays a key role in the therapeutic path of myasthenia gravis. For years, sternotomy has been the traditional approach for removing anterior mediastinal lesions, although the robotic thymectomy is now widely performed. The literature is still lacking in papers comparing the two approaches and evaluating long-term oncological and neurological outcomes. This study aims to analyze the postoperative results of open and robotic thymectomy for thymic neoplasms in myasthenic patients. Surgical, oncological and neurological data of myasthenic patients affected by thymic neoplasms and surgically treated with extended thymectomy, both with the open and the robotic approach, in six Italian Thoracic Centers between 2011 and 2021 were evaluated. A total of 213 patients were enrolled in the study: 110 (51.6%) were treated with the open approach, and 103 (48.4%) were treated with robotic surgery. The open surgery, compared with the robotic, presented a shorter operating time (p < 0.001), a higher number of postoperative complications (p = 0.038) and longer postoperative hospitalization (p = 0.006). No other differences were observed in terms of surgical, oncological or neurological outcomes. The robotic approach can be considered safe and feasible, comparable to the open technique, in terms of surgical, oncological and neurological outcomes.

22 April 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Giovanni MattioniGiovanni Mattioni
Giovanni Mattioni
RFRaveglia Federico
Raveglia Federico
AOAndrea Onofri
Andrea Onofri
AAAndrea Anastasi
Andrea Anastasi
GCGraziana Carleo
Graziana Carleo
OGon behalf of the SIET Residents’ Committee Collaborative Group
on behalf of the SIET Residents’ Committee Collaborative Group
Background: Surgical residents are a high-risk population for burnout, yet no studies have assessed its prevalence among thoracic surgery residents in Europe or Italy. Methods: A nationwide cross-sectional survey was conducted among Italian thoracic surgery residents to assess burnout and quality of life. The Maslach Burnout Inventory measured burnout risk, while tailored questions evaluated quality of life. Univariate and multivariable analyses identified burnout risk factors, and χ2 tests explored relevant associations between variables. Results: Of 193 eligible residents, 98 (50.8%) completed the survey. High burnout risk was identified in 60.2% of respondents. Independent risk factor associations between burnout risk and low perceived inclusion and aggregation, low colleague quality, low residency program rating, low personal life satisfaction, perceived lack of valorization, and exposure to sexual harassment were not significant in multivariable models. No differences in burnout risk were found across gender, geographic location, or training year. Conclusions: Burnout among Italian thoracic surgery residents underscores systemic challenges such as excessive administrative demands, insufficient mentorship, limitations to self-care, and gaps in theoretical training. Addressing these issues requires comprehensive reforms, including curriculum enhancement, strengthened mentorship, improved administrative support, and accessible mental health resources. A multi-level intervention strategy is essential to enhance resident well-being and training quality.